EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integrated multiparametric ultrasound and biomarker assessment for clinical staging and treatment response prediction in cervical cancer: A single-center retrospective study

Tao Lyu, Minghui Li iD, Huimin Li, Ling He, Wei Zhang, Xuan Shi

Cancer Biomarkers · 2026-06 · 43

DOI: 10.1177/18758592261479724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, online erschienen am 22.08.2026. Verfasst von Tao Lyu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Diagnosis, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate staging and treatment response assessment remain challenging in cervical cancer management. This study investigated the diagnostic and prognostic value of integrating ultrasonographic parameters with serum and tissue biomarkers.

Methods

This retrospective study included 392 patients with histopathologically confirmed cervical cancer treated between January 2019 and December 2024. All patients underwent comprehensive ultrasonographic evaluation and biomarker assessment (SCC-Ag, CEA, CA125, CA19-9, NLR, Ki-67, HPV status) before treatment. An integrated scoring system was developed and validated. In 324 patients receiving concurrent chemoradiotherapy, dynamic changes were monitored at baseline, mid-treatment, and post-treatment. Multivariate analysis identified independent prognostic factors for survival analysis.

Results

The integrated scoring system demonstrated superior staging performance (sensitivity 92.6%, specificity 88.4%, AUC 0.94) compared to ultrasound alone (78.4%, 72.6%, 0.82) or biomarkers alone (74.2%, 68.4%, 0.78). Tumor volume strongly correlated with SCC-Ag levels in squamous cell carcinoma. The combination of >50% tumor volume reduction and >60% SCC-Ag decrease at mid-treatment predicted complete response with 91.2% sensitivity and 86.4% specificity. Prognostic stratification identified three risk groups with significantly different 3-year progression-free survival rates: low-risk 62.1%, intermediate-risk 54.6%, and high-risk 33.8%.

Conclusions

Integration of ultrasonographic parameters and biomarker profiles provides superior diagnostic accuracy for cervical cancer staging and enables early prediction of treatment response, potentially guiding personalized treatment decisions and surveillance strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsBiomarkers, TumorHumansFemaleRetrospective StudiesNeoplasm StagingUltrasonographyMiddle AgedPrognosisAdultAgedTreatment OutcomeChemoradiotherapyAntigens, NeoplasmSerpins

Stichwörter der Autor:innen

Ki-67SCC-Agbiomarkerscervical cancerparametrial invasionprognostic modelrisk stratificationtreatment responsetumor volumeultrasound

Substanzen

Biomarkers, Tumorsquamous cell carcinoma-related antigenAntigens, NeoplasmSerpins

Autor:innen und Institutionen

  • Department of Ultrasound Diagnosis, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, China.

ORCID-Profile: Minghui Li

Zitieren

APA

Lyu, T., Li, M., Li, H., He, L., Zhang, W., & Shi, X. (2026). Integrated multiparametric ultrasound and biomarker assessment for clinical staging and treatment response prediction in cervical cancer: A single-center retrospective study. Cancer Biomarkers, 43. https://doi.org/10.1177/18758592261479724

Vancouver

Lyu T, Li M, Li H, He L, Zhang W, Shi X. Integrated multiparametric ultrasound and biomarker assessment for clinical staging and treatment response prediction in cervical cancer: A single-center retrospective study. Cancer Biomarkers. 2026;43. doi:10.1177/18758592261479724

BibTeX
@article{Lyu2026,
  author = {Lyu, Tao and Li, Minghui and Li, Huimin and He, Ling and Zhang, Wei and Shi, Xuan},
  title = {Integrated multiparametric ultrasound and biomarker assessment for clinical staging and treatment response prediction in cervical cancer: A single-center retrospective study},
  journal = {Cancer Biomarkers},
  year = {2026},
  volume = {43},
  doi = {10.1177/18758592261479724}
}
Kostenlos starten →